Non-muscle Invasive Bladder Cancer
📧 Sign up to get email alerts when something new happens for Non-muscle Invasive Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-08-19Clinical Trial Update: Codex: Study of Inodiftagene Vixteplasmid (BC-819) in Unresponsive NMIBC [Phase 2]
Phase 2 trial of Inodiftagene Vixteplasmid (BC-819) in unresponsive non-muscle invasive bladder cancer was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2020-08-13Clinical Trial Update: Study of Continuous APL-1202 Treatment in Subjects With High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) Relapsed From Intravesical Chemo/BCG Therapy [Phase 2]
Phase 2 study of continuous APL-1202 in patients with high-risk non-muscle-invasive bladder cancer that relapsed after intravesical chemo/BC…
-
CLINICAL_TRIALS trial_result · 2020-07-31Clinical Trial Update: Pembrolizumab in Intermediate Risk Recurrent Non-muscle Invasive Bladder Cancer (NMIBC) [Phase 1, Phase 2]
A phase 1/2 clinical trial of pembrolizumab in intermediate-risk recurrent non-muscle invasive bladder cancer has been terminated; results w…
-
CLINICAL_TRIALS trial_result · 2020-07-20Clinical Trial Update: Study of APL-1202 in Non-Muscle Invasive Bladder Cancer Patients Who Are Resistant to One Induction Course of BCG Treatment [Phase 1, Phase 2]
Phase 1/2 clinical trial of APL-1202 in patients with non-muscle invasive bladder cancer resistant to one induction course of BCG treatment …
-
CLINICAL_TRIALS trial_result · 2020-05-12Clinical Trial Update: Study of Vicinium for Treating Patients With Non-Invasive Urothelial Carcinoma In Situ [Phase 2]
Phase 2 clinical trial update for Vicinium in non-invasive urothelial carcinoma in situ of the bladder has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-01-22Clinical Trial Update: Study of Bacillus Calmette-Guerin (BCG) Combined With PANVAC Versus BCG Alone in Adults With High Grade Non-Muscle Invasive Bladder Cancer Who Failed At Least 1 Course of BCG [Phase 2]
Phase 2 study comparing BCG alone vs BCG plus PANVAC in adults with high-grade non-muscle invasive bladder cancer after BCG failure; results…
-
CLINICAL_TRIALS trial_result · 2019-08-30Clinical Trial Update: Study to Evaluate the Efficacy and Safety Of Intravesical Nanoxel®M In BCG Refractory NMIBC [Phase 3]
Phase 3 trial evaluating intravesical Nanoxel®M for efficacy and safety in BCG-refractory non-muscle invasive bladder cancer; the study stat…
-
CLINICAL_TRIALS trial_result · 2019-06-17Clinical Trial Update: CAVATAK (CVA21) in Non-muscle Invasive Bladder Cancer (VLA-012 CANON) [Phase 1]
Phase 1 trial update for CAVATAK (CVA21) in non-muscle invasive bladder cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-05-16Clinical Trial Update: Bladder PREserVation by RadioTherapy and Immunotherapy in BCG Unresponsive Non-muscle Invasive Bladder Cancer [Phase 2]
Phase 2 trial update investigating bladder preservation using radiotherapy and immunotherapy in patients with BCG-unresponsive non-muscle-in…
-
CLINICAL_TRIALS research · 2018-07-24Clinical Trial Update: The Difference of Two Year Recurrence Rate According to Anesthetic Method During Transurethral Resection of Bladder Mass in Patients With Non-muscle Invasive Bladder Cancer: Prospective, Randomized, Clinical Phase II Study [NA]
A prospective randomized Phase II trial evaluating whether anesthetic method during transurethral resection of bladder mass affects two-year…
-
CLINICAL_TRIALS trial_result · 2018-03-22Clinical Trial Update: Value of Immediate Post-operative Intravesical Epirubicin in Intermediate&High Risk Non Muscle Invasive Bladder Cancer [Phase 4]
A Phase 4 clinical trial evaluating the value of immediate post-operative intravesical epirubicin in intermediate- and high-risk non-muscle …
-
CLINICAL_TRIALS trial_result · 2017-12-15Clinical Trial Update: Efficacy and Safety Study of Apaziquone vs. Placebo in Patients With Non-Muscle Invasive Bladder Cancer (NMIBC) [Phase 3]
Phase 3 trial of apaziquone versus placebo in non-muscle invasive bladder cancer was terminated; results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-08-22Clinical Trial Update: Ethacrynic Acid Elimination in Non-Muscle Invasive Bladder Cancer Patients Undergoing Transurethral Resection [Phase 1]
Phase 1 trial evaluating the pharmacokinetics and elimination of Ethacrynic acid in patients with non-muscle-invasive bladder cancer undergo…
-
CLINICAL_TRIALS trial_result · 2017-08-15Clinical Trial Update: Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-612) [Phase 3]
Phase 3 trial SPI-612 evaluated a single-dose intravesical apaziquone after TURBT for non-muscle-invasive bladder cancer; results have been …
-
CLINICAL_TRIALS research · 2017-07-21Clinical Trial Update: "En Bloc" Resection of NMIBC: a Prospective， Single Centre，Randomized Study [Phase 4]
A Phase 4, prospective, single-centre randomized study evaluating en bloc resection for non-muscle invasive bladder cancer (NMIBC) at Tongji…
-
CLINICAL_TRIALS trial_result · 2017-06-16Clinical Trial Update: Safety of Pre-TURBT Intravesical Instillation of Escalating Doses of TC-3 Gel and MMC in NMIBC Patients [Phase 2]
Phase 2 safety study evaluating escalating doses of TC-3 Gel in combination with intravesical mitomycin C for non-muscle invasive bladder ca…
-
CLINICAL_TRIALS trial_result · 2017-06-16Clinical Trial Update: Pre-TURBT TC-3 Gel Intravesical Instillation in NMIBC [NA]
A completed study evaluating pre-TURBT instillation of TC-3 Gel intravesically in non-muscle-invasive bladder cancer.
-
CLINICAL_TRIALS trial_result · 2017-06-05Clinical Trial Update: In the Prediction of Recurrence and Progression of NMIBC; EORTC or CUETO or Both? [Phase 4]
A Phase 4 trial assessing predictive models for recurrence and progression in non-muscle invasive bladder cancer, comparing EORTC and CUETO …
-
CLINICAL_TRIALS research · 2017-05-23Clinical Trial Update: Storz Professional Image Enhancement System Versus White Light Imaging Assisted TURBT for Treatment of NMIBC [NA]
This clinical trial update compares the Storz Professional Image Enhancement System with white-light imaging for transurethral resection of …
-
CLINICAL_TRIALS research · 2017-05-23Clinical Trial Update: Solifenacin, Levofloxacin or Lornoxicam, Which Is Ideal for Management of Intravesical Instillation BCG Side Effects? [Phase 4]
A Phase 4 clinical trial compares solifenacin, levofloxacin, and lornoxicam for managing side effects of intravesical BCG therapy in non-mus…
-
CLINICAL_TRIALS research · 2017-05-16Clinical Trial Update: A New Prognostic Model for Predicting the Outcome of Patients With Non-muscle Invasive Bladder Cancer (NMIBC)
The document announces an update on a prognostic model intended to predict outcomes for patients with non-muscle invasive bladder cancer.
-
CLINICAL_TRIALS research · 2017-04-06Clinical Trial Update: Evaluation of Immediate Preoperative Instillation (IPOI) of Mitomycin C Compared to Early Postoperative Instillation (IPOP) in Non-muscle Invasive Bladder Cancer [Phase 2]
Phase 2 clinical trial evaluating immediate preoperative instillation of mitomycin C versus early postoperative instillation for non-muscle-…
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: Single Immediate Instillation of EO9 After TURBT in Patients With Non-muscle-invasive Bladder Cancer (NMIBC) [Phase 2, Phase 3]
A Phase 2/Phase 3 trial evaluating a single immediate instillation of EO9 after TURBT in non-muscle-invasive bladder cancer has been termina…
-
CLINICAL_TRIALS trial_result · 2016-12-13Clinical Trial Update: Efficacy and Safety of Multi-Instillations of Apaziquone in Patients With Non-Muscle Invasive Bladder Cancer [Phase 3]
Phase 3 trial evaluating multi-instillations of apaziquone for non-muscle invasive bladder cancer was terminated, and results on efficacy an…
-
CLINICAL_TRIALS research · 2016-09-09Clinical Trial Update: Effect on Xpert® Bladder Test of Urines Inflammatory Milieu Induced by BCG Treatment of Patients With NMIBC [NA]
This clinical trial update assesses how the Xpert bladder test is affected by the inflammatory milieu in urine induced by Bacillus Calmette-…